Theme: Advancements and Outbreaks in the field of Neuro-Oncology Surgery



With the coordination of organizing committee, 5th International Conference on Neuro Oncology and Neuro Surgery  will be scheduled during  August 22-23, 2022 Zurich, Switzerland. The conference mainly focuses on the theme “Advancements and Outbreaks in the field of Neuro-Oncology Surgery”. This gathering is to promote quality and useful  information through the keynote sessions, poster presentations, oral presentations, symposia, workshops, and exhibitions in this conference. This conference provides you with the new insights of technology and advancements in the field of Neurology and Oncology.


We are welcoming Scientists, Doctors, Academician, Researcher, Students, Business Entrepreneurs and every other interested person for this Conference.

  • Oncologist
  • Researchers
  • Scientists
  • Health care experts
  • Neuro Scientist
  • Investigators
  • Neuro Oncologist
  • Nutritionists
  • Clinicians
  • Neurologist
  • Physicians
  • Nurse practitioners
  • Health care analysts
  • Doctors
  • Academic researchers
  • Professors
  • Students
  • Research Institutes
  • Business delegates
  • Young Researchers
  • Advertising and Promotion Agency Executives
  • Professionals in media sector
  • Medical colleges
  • Global Cancer Organizations
  • NGO & Associations
  • Fund Raisers for Cancer Treatment
  • Medical & Pharmaceutical Companies

Track 1: Neuroscience and Neuro-Oncology

Neuroscientists are interested in the brain's impact on behaviour and intellectual abilities. Neuroscience is concerned not only with the normal functioning of the sensory system, but also with what happens to the sensory system when people have neurological, mental, or neurodevelopmental problems.

The European Society for Medical Oncology's "Basics for Clinicians" framework relies heavily on neuro-oncology. Despite the fact that vital cerebrum tumours are uncommon and rarely encountered outside of specific oncology departments, basic knowledge of the arrangement and board recommendations for gliomas is crucial to ensure adequate patient attention in each therapeutic context.

Track 2: Molecular Neuro-Oncology and Genomics

Molecular neuro-oncology has recently begun to explain the evolving nature of brain tumours and to define oncogenic pathways that may be amenable to targeted treatment. Brain tumours frequently upregulate development factor flagging pathways, which may contribute to oncogenesis via autocrine and paracrine mechanisms.

Genomics is the study of a living organism's entire genome, which includes components from inherited characteristics. Genomics arranges, gathers, and breaks down the design and capacity of genomes using a combination of recombinant DNA, DNA sequencing tools, and bioinformatics. It differs from 'conventional hereditary attributes' in that it considers a life form's entire supply of intrinsic material rather than individual qualities or quality items.

Track 3: Pediatrics and Geriatrics Neuro-Oncology

Age has remained one of the most important factors of risk for the progression of certain brain tumours, benefit from and resiliency to brain tumour treatment, and overall outcome. There are considerable differences throughout the range of critical cerebrum tumours based on explicit histology from three perspectives.

The treatment of children with brain and spinal cord tumours is incredibly uncertain. Cerebral tumours in children can be stubborn, and they frequently do not respond to traditional chemotherapy or radiation. to some extent because the mind is relatively protected from medicines (the blood-cerebrum blockage), partially because medical operation in the cerebrum must be very precise in order to avoid injury to cerebrum tissue, and to some extent because radiation therapy to the cerebrum  can make injury typical mind tissue.

Synapses, despite having a well controlled safe framework, are defenceless against the damages caused by immune system disorders, such as different scleroses. As a result of an immune system infection, the body's invulnerable structure begins to attack its own cells and proteins, mistaking them for foreign particles. As a result, a chain of preventing damages occurs, which can be fatal, especially when such assaults occur inside the head.

Juvenile organisms are undifferentiated organisms "Unspecialized cell that has the ability to transform into a specific type of cell when it is young. These cells have the appearance of a clear sheet of paper "cellular units They resemble clear cells that may transform into numerous types of particular cells, much like a clear piece of paper. Immature microorganisms can continue to isolate as long as they are alive (this is referred to as "self-re-establishing"), and they have two notable features: they can produce new undifferentiated organisms and they can transform into various types of more particular cells. There are neural undifferentiated cells in the cerebrum.

Track 5: Cancer and Brain Tumors

A brain tumour is a mass or growth of abnormal cells in the brain.

There are many different types of brain tumours. Some brain tumours are benign (pleasant), while others are malignant (hazardous) (threatening). Tumors in the cerebrum might begin in the mind (essential cerebrum tumours), or malignant growth can begin in other parts of your body and spread to your cerebrum (auxiliary, or metastatic, mind tumors).

The rate at which a brain tumour grows might vary dramatically. The rate of growth, like the size of a brain tumour, determines what your sensory system's capacity will be.The type of cerebrum tumour you have, as well as its size and location, influence your treatment options.

Track 6: Pregnancy and Neuro-Oncology

Chemotherapy is the use of toxic medicines to kill a cancerous development in your body. Chemotherapy and other anticancer drugs might harm the hatchling, induce birth abnormalities, and result in preterm delivery, especially if used during the first trimester of pregnancy. During the second and third trimesters, a few chemotherapies and other cancer-fighting drugs are safe to use.

Track 7: Neuro-Oncology and Vision Science

Chemotherapy is the use of toxic medicines to kill a cancerous development in your body. Chemotherapy and other anticancer drugs might harm the hatchling, induce birth abnormalities, and result in preterm delivery, especially if used during the first trimester of pregnancy. During the second and third trimesters, a few chemotherapies and other cancer-fighting drugs are safe to use.

Track 8: Neurostimulation, Glutamate Neurotransmission and Neuroimaging in Cognitive Neuroscience

Neurostimulation relieves pain by disrupting the anguish signals that travel between the spinal cord and the brain. Overall, it outmanoeuvres your misery.

Glutamate is a prominent synapse found in more than 90% of all neural connections in the cerebrum and is a naturally occurring particle used by nerve cells to communicate with other cells in the focused sensory system.

Track 9: Biomarkers in Neuro-Oncology

Biomarkers are used to educate doctors on how to treat brain tumours. One application is to properly group tumours with similar hereditary/genomic characteristics and to arrange preparations separately for each gathering. The biomarker is used to predict patient reaction so that the optimum treatment for patients can be chosen based on their tumour characteristics. Given the relatively small numbers of individuals available for preliminaries, preliminary plans that pick unselected participants are insufficient for identifying treatments that are successful only in subsets of patients.

Track 10: Neuropathology and Neuroradiology

Neuropathology plays an important role in describing the aetiology of neurodegenerative illnesses, including kinds of neurodegeneration associated with iron accumulation in the cerebrum (NBIA). Notwithstanding major differences, a few hereditarily diverse kinds of NBIA have normal features, such as the presence of neuroaxonal spheroids, despite iron evidence. Different kinds of NBIA also display tau or synuclein pathology, implying that they are linked to both Alzheimer's and Parkinson's diseases. This section summarises what has been learned through studying human patient tissues.

Neuroradiology is a branch of radiology that focuses on using neuroimaging techniques to analyse and depict anomalies of the focal and fringe sensory systems, spine, and head and neck.

Track 11: Psycho-Oncology and Psychosocial Advances

The psycho-role, oncologist's as played by the dying, extends beyond the treatment of mental symptoms and disorders to areas such as existential difficulties, family and guardian support, deprivation, expert patient correspondence, schooling, and preparation.

Track 12: Surgical Neurology and Neuro-Oncology

It is the therapeutic specialty concerned with locating and treating patients with injuries to, or illnesses/problems of, the brain, spinal cord and spinal segment, and fringe nerves throughout the body. Both adult and paediatric patients are included in neurosurgical care's claim to fame. A neurological specialist may give careful or maybe non-careful consideration depending on the idea of the damage or sickness.

Track 13: Neuro-Oncology Cognition Measurement and Treatment

Psychological abilities can be assessed using a variety of tests to determine whether or not someone has issues with intuition, feelings, or behaviour. The results of the test can aid in the selection of appropriate medications to improve an individual's psychological capabilities.

Various drugs are available depending on the type of mental alteration a person is experiencing and the cause. Medicine, behavioural adjustments, and lifestyle changes may be administered to help with these conditions.Medication

Genetic medicine is the combination and application of genomic technologies that allows biomedical scientists and physicians to gather data from a large study population and determine the infectious and genetic underpinnings of medication responsiveness. Genome structure, functional genomics, epigenomics, genome scale population genomics, frameworks evaluation, pharmacogenomics, and proteomics are all covered.

Most Common Genetic Disorders:

  • Down syndrome
  • Thalassemia.
  • Cystic Fibrosis.
  • Tay-Sachs disease.
  • Sickle Cell Anaemia

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 22-23, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View